8-Methoxypsoralen is metabolized rapidly and completely in man. Most of the metabolites presently known have their origin in a metabolic attack on the furan moiety yielding an aryl-diol and aryl-acetic-acid and are excreted as conjugates.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/BF03189450 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Synthesis of new 1,4-dihydropyridine derivative, anti-cancer, bacterial activity, molecular docking and adsorption, distribution, metabolism and excretion analysis.
Future Med Chem
December 2024
Department of Chemistry, College of Science, King Saud University, P.O. Box 2455, Riyadh, 11451, Saudi Arabia.
The amination and cyclization method developed a new strategy for designing and assembling new 1,4-dihydropyridine derivatives of compounds 3a-g and 4a-g. Newly prepared pyridine compounds are more economical, and reduce the reaction time. FT-IR, H-NMR, 13C-NMR, mass spectroscopy and elemental analyses elucidated the synthesized derivatives.
View Article and Find Full Text PDFBergapten attenuates sepsis-induced acute lung injury in mice by regulating Th17/Treg balance.
Inhal Toxicol
November 2024
Department of Emergency Medicine, Hanzhong Central Hospital, Hanzhong, China.
Article Synopsis
- Sepsis-induced immune system abnormalities can lead to organ dysfunction, and maintaining the balance between Th17 and Treg cells is crucial for immune health.
- The study used mouse models and various scientific methods to evaluate the effects of bergapten, a natural compound, on inflammation during sepsis.
- Results showed that bergapten reduced lung damage and inflammation by restoring the Th17/Treg balance, suggesting its potential as a treatment for sepsis-related conditions.
Novel Combination Therapy for Heart Failure: Trimebutine-Methoxsalen Identified through Synergistic Network Virtual Screening and Experimental Validation.
J Chem Inf Model
September 2024
State Key Laboratory of Bioreactor Engineering, Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism, Frontiers Science Center for Materiobiology and Dynamic Chemistry, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China.
Combination therapy is increasingly favored by pharmaceutical companies and researchers as an effective way to quickly discover new drugs with excellent efficacy, especially in the treatment of complex diseases. Previously, we successfully developed a computational screening method to identify such combinations, although it fell short in elucidating their synergistic mechanisms. In this work, we have transitioned to a highest single agent (HSA) synergy model for network screening, which streamlines the discovery of promising combinations and facilitates the investigation of their synergistic effects.
View Article and Find Full Text PDFChromenone: An emerging scaffold in anti-Alzheimer drug discovery.
Bioorg Med Chem Lett
October 2024
Department of Pharmaceutical Chemistry, Delhi Pharmaceutical Sciences & Research University, Delhi 110017, India. Electronic address:
Alzheimer's disease (AD) presents a growing global health concern. In recent decades, natural and synthetic chromenone have emerged as promising drug candidates due to their multi-target potential. Natural chromenone, quercetin, scopoletin, esculetin, coumestrol, umbelliferone, bergapten, and methoxsalen (xanthotoxin), and synthetic chromenone hybrids comprising structures like acridine, 4-aminophenyl, 3-arylcoumarins, quinoline, 1,3,4-oxadiazole, 1,2,3-triazole, and tacrine, have been explored for their potential to combat AD.
View Article and Find Full Text PDFEvaluation of a panel of furochromenones as the activator and inhibitor of tyrosinase.
Chem Biol Drug Des
May 2024
Department of Biotechnology, Indian Institute of Technology Hyderabad (IITH), Sanga Reddy, Telangana, India.
Tyrosinase is a copper-containing enzyme involved in the biosynthesis of melanin pigment. While the excess production of melanin causes hyperpigmentation of human skin, hypopigmentation results in medical conditions like vitiligo. Tyrosinase inhibitors could be used as efficient skin whitening agents and tyrosinase agonists could be used for enhanced melanin synthesis and skin protection from UV exposure.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!